Research Summary
Insulin glargine is a long-acting insulin analog used to manage blood sugar levels in individuals with diabetes. It is designed to provide a steady and prolonged release of insulin, mimicking the basal insulin secretion pattern of the body. Insulin glargine works by lowering blood sugar levels by facilitating the uptake of glucose into cells and inhibiting the production of glucose in the liver. Unlike regular insulin, insulin glargine has a slower onset and a more consistent effect, helping to maintain stable blood sugar levels throughout the day and night. It is typically administered once daily, preferably at the same time each day, to provide continuous coverage and reduce the risk of hypoglycemia. Insulin glargine is available in various formulations, including Lantus, Basaglar, and Toujeo, and is commonly prescribed for individuals with type 1 and type 2 diabetes who require basal insulin therapy to manage their condition effectively.
According to DIResearch's in-depth investigation and research, the global Insulin Glargine market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Insulin Glargine include Sanofi-Aventis, Ganlee, Biocon etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Insulin Glargine. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Insulin Glargine market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Insulin Glargine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Insulin Glargine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Insulin Glargine Include:
Sanofi-Aventis
Ganlee
Biocon
Insulin Glargine Product Segment Include:
Single Dose Vial
Pre-filled Syringe
Insulin Glargine Product Application Include:
Treat Type2 Diabetes
Treat Type1 Diabetes
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Insulin Glargine Industry PESTEL Analysis
Chapter 3: Global Insulin Glargine Industry Porter's Five Forces Analysis
Chapter 4: Global Insulin Glargine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Insulin Glargine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Insulin Glargine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Insulin Glargine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Insulin Glargine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Insulin Glargine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Insulin Glargine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Insulin Glargine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Insulin Glargine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Insulin Glargine Market Overview 1.1 Product Definition and Statistical Scope 1.2 Insulin Glargine Product by Type 1.2.1 Global Insulin Glargine Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Single Dose Vial 1.2.3 Pre-filled Syringe 1.3 Insulin Glargine Product by Application 1.3.1 Global Insulin Glargine Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Treat Type2 Diabetes 1.3.3 Treat Type1 Diabetes 1.4 Global Insulin Glargine Market Revenue and Sales Analysis 1.4.1 Global Insulin Glargine Market Size Analysis (2019-2030) 1.4.2 Global Insulin Glargine Market Sales Analysis (2019-2030) 1.4.3 Global Insulin Glargine Market Sales Price Trend Analysis (2019-2030) 1.5 Insulin Glargine Market Development Status and Trends 1.5.1 Insulin Glargine Industry Development Status Analysis 1.5.2 Insulin Glargine Industry Development Trends Analysis 2 Insulin Glargine Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Insulin Glargine Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Insulin Glargine Market Analysis by Regions 4.1 Insulin Glargine Overall Market: 2023 VS 2024 VS 2030 4.2 Global Insulin Glargine Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Insulin Glargine Revenue and Market Share by Region (2019-2024) 4.2.2 Global Insulin Glargine Revenue Forecast by Region (2025-2030) 4.3 Global Insulin Glargine Sales and Forecast Analysis (2019-2030) 4.3.1 Global Insulin Glargine Sales and Market Share by Region (2019-2024) 4.3.2 Global Insulin Glargine Sales Forecast by Region (2025-2030) 4.4 Global Insulin Glargine Sales Price Trend Analysis (2019-2030) 5 Global Insulin Glargine Market Size by Type and Application 5.1 Global Insulin Glargine Market Size by Type 5.1.1 Global Insulin Glargine Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Insulin Glargine Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Insulin Glargine Market Size by Application 5.2.1 Global Insulin Glargine Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Insulin Glargine Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Insulin Glargine Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Insulin Glargine Market Size by Type 6.3.1 North America Insulin Glargine Sales by Type (2019-2030) 6.3.2 North America Insulin Glargine Revenue by Type (2019-2030) 6.4 North America Insulin Glargine Market Size by Application 6.4.1 North America Insulin Glargine Sales by Application (2019-2030) 6.4.2 North America Insulin Glargine Revenue by Application (2019-2030) 6.5 North America Insulin Glargine Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Insulin Glargine Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Insulin Glargine Market Size by Type 7.3.1 Europe Insulin Glargine Sales by Type (2019-2030) 7.3.2 Europe Insulin Glargine Revenue by Type (2019-2030) 7.4 Europe Insulin Glargine Market Size by Application 7.4.1 Europe Insulin Glargine Sales by Application (2019-2030) 7.4.2 ? Europe Insulin Glargine Revenue by Application (2019-2030) 7.5 Europe Insulin Glargine Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Insulin Glargine Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Insulin Glargine Market Size by Type 8.3.1 China Insulin Glargine Sales by Type (2019-2030) 8.3.2 China Insulin Glargine Revenue by Type (2019-2030) 8.4 China Insulin Glargine Market Size by Application 8.4.1 China Insulin Glargine Sales by Application (2019-2030) 8.4.2 China Insulin Glargine Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Insulin Glargine Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Insulin Glargine Market Size by Type 9.3.1 APAC (excl. China) Insulin Glargine Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Insulin Glargine Revenue by Type (2019-2030) 9.4 APAC (excl. China) Insulin Glargine Market Size by Application 9.4.1 APAC (excl. China) Insulin Glargine Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Insulin Glargine Revenue by Application (2019-2030) 9.5 APAC (excl. China) Insulin Glargine Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Insulin Glargine Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Insulin Glargine Market Size by Type 10.3.1 Latin America Insulin Glargine Sales by Type (2019-2030) 10.3.2 Latin America Insulin Glargine Revenue by Type (2019-2030) 10.4 Latin America Insulin Glargine Market Size by Application 10.4.1 Latin America Insulin Glargine Sales by Application (2019-2030) 10.4.2 Latin America Insulin Glargine Revenue by Application (2019-2030) 10.5 Latin America Insulin Glargine Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Insulin Glargine Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Insulin Glargine Market Size by Type 11.3.1 Middle East & Africa Insulin Glargine Sales by Type (2019-2030) 11.3.2 Middle East & Africa Insulin Glargine Revenue by Type (2019-2030) 11.4 Middle East & Africa Insulin Glargine Market Size by Application 11.4.1 Middle East & Africa Insulin Glargine Sales by Application (2019-2030) 11.4.2 Middle East & Africa Insulin Glargine Revenue by Application (2019-2030) 11.5 Middle East & Africa Insulin Glargine Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Insulin Glargine Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Insulin Glargine Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Insulin Glargine Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Insulin Glargine Average Sales Price by Manufacturers (2020-2024) 12.2 Insulin Glargine Competitive Landscape Analysis and Market Dynamic 12.2.1 Insulin Glargine Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Sanofi-Aventis 13.1.1 Sanofi-Aventis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Sanofi-Aventis Insulin Glargine Product Portfolio 13.1.3 Sanofi-Aventis Insulin Glargine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Ganlee 13.2.1 Ganlee Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Ganlee Insulin Glargine Product Portfolio 13.2.3 Ganlee Insulin Glargine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Biocon 13.3.1 Biocon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Biocon Insulin Glargine Product Portfolio 13.3.3 Biocon Insulin Glargine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Insulin Glargine Industry Chain Analysis 14.2 Insulin Glargine Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Insulin Glargine Typical Downstream Customers 14.4 Insulin Glargine Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support